Screener
Ardelyx
ARDXArdelyx is a commercial-stage biopharmaceutical company specializing in the discovery, development, and commercialization of first-in-class small molecule therapies.
Earnings
Next report
Oct 29, 2026 (in a month)Revenue estimate$129.2M
EPS estimate-$0.03
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Ardelyx is a commercial-stage biopharmaceutical company specializing in the discovery, development, and commercialization of first-in-class small molecule therapies. The company focuses on addressing significant unmet medical needs in gastrointestinal and renal health through its proprietary sodium/hydrogen exchanger 3 (NHE3) inhibitor platform.
Competitive position
Ardelyx maintains a unique position as a provider of first-in-class NHE3 inhibitors, offering a novel mechanism of action compared to traditional secretagogues and phosphate binders.
GeographiesUnited States
Customer segmentsSpecialty healthcare providers, Chronic disease patients, Healthcare systems
Business modelDirect-to-market product sales, Research and development, Licensing and collaborations
SuppliersSmall molecule manufacturing, Clinical research organizations, Raw material suppliers
CustomersSpecialty pharmacies, Wholesale drug distributors, Dialysis clinics, Hospitals
CountryUnited States of America
Listed2014
Employees267.0
CEOMichael G. Raab
SectorHealthcare
IndustryBiotechnology
Websiteardelyx.com
FilingsSEC EDGAR
FAQ
- What is Ardelyx's market cap?
- Ardelyx (ARDX) has a market capitalization of $875.3M and trades on NASDAQ.
- What is Ardelyx's revenue and profitability?
- Ardelyx generated $450.9M in trailing twelve-month revenue with a net loss of $55.7M, representing a net margin of -12.4%. Gross margin stands at 94.4%, with free cash flow of -$103.5M. The latest reported period is Q2 2026.
- Who are Ardelyx's competitors?
- Ardelyx's key competitors include Ironwood Pharmaceuticals, Inc., Bausch Health Companies Inc., AbbVie Inc., and others. These companies compete in similar markets and product categories.
- Who does Ardelyx partner with?
- Ardelyx's notable partners include SLR Investment Corp., HealthCare Royalty Partners.
- Where is Ardelyx headquartered?
- Ardelyx is headquartered in United States of America and employs approximately 267 people. It has been publicly traded since 2014.
